Monoclonal Antibody Appears Effective and Safe in Asthma Phase IIa Trial

May 21, 2013 — A novel approach to obstructing the runaway inflammatory response implicated in some types of asthma has shown promise in a Phase IIa clinical trial, according to U. S. researchers......

Read more: sciencedaily.com



Regeneron, Sanofi Asthma Drug Shows Promising Results

A new experimental asthma drug is giving hope to people who have asthma. Dupilumab, which is developed by Sanofi and Regeneron Pharmaceuticals, has reduced episodes of asthma by as much as 87 percent in mid-stage trials making it a potential game changer. If approved for release then it could give new hope for the 25 million Americans that suffer from this ailment......

Read more: studentnewsie.com



Dustless chalk may trigger asthma symptoms in children with milk allergies

Children with milk allergies may experience asthma symptoms after inhaling chalk dust containing casein, according to recent study results published in Annals of Allergy, Asthma & Immunology......

Read more: healio.com